Mar 1, 2021 - Rechecking bone mineral density (BMD) after three years does not add additional prognostic information. Serial BMD testing is not useful in estimating fracture risk and assessing the need for treatment because BMD does not change much within three years.
American Family Physician : POEMs
May 1, 2019 - Denosumab appears to be effective in reducing the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Treatment with denosumab does not increase the risk of cancer or death but might increase the risk of infection. However, more studies are required.
American Family Physician : Medicine by the Numbers
Nov 15, 2018 - The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older.
American Family Physician : U.S. Preventive Services Task Force
navigate_before 1 navigate_next